Immix Biopharma, Inc. (IMMX) Financials

IMMX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 95.8 million 11.5 million
Dec. 31, 2025 104.8 million 11.0 million
Sept. 30, 2025 20.1 million 11.8 million
June 30, 2025 15.6 million 11.0 million

IMMX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -9.9 million 575565
Dec. 31, 2025 -11.2 million 570796
Sept. 30, 2025 -6.3 million 470471
June 30, 2025 -5.4 million 532249

IMMX Net Income

No data available :(

IMMX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 90.6 million 912343 1.0 million
Dec. 31, 2025 100.4 million 933625 1.1 million
Sept. 30, 2025 15.9 million - 1.1 million
June 30, 2025 11.6 million - 1.0 million

IMMX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 38.3 million
Dec. 31, 2025 38.3 million
Sept. 30, 2025 31.9 million
June 30, 2025 30.0 million

IMMX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 32486 6.0 million 4.8 million -
Dec. 31, 2025 165126 5.7 million 5.2 million -
Sept. 30, 2025 372456 4.6 million 3.1 million -
June 30, 2025 127630 4.0 million 2.7 million -

IMMX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 130766
Dec. 31, 2025 - 90631
Sept. 30, 2025 - -
June 30, 2025 - 79835

IMMX

Price: $8.74

52 week price:
1.94
11.61

Earnings Per Share: -0.92 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 12035

Market Capitalization: 562.4 million

Links: